Future Prospects of Global Laboratory Proficiency Testing Market

![]() |
Genomics Market |
From 2019 to 2026, the genomics market is expected to grow
significantly, owing to increased application scope and rising demand for
precision medicine. The growing global burden of cancer has resulted in
increased government support in the form of funds for genomics projects. The
increased number of prenatal genetic screening programmes will also drive
market demand.
Genomics is the study of genomes and includes DNA sequencing
methods, recombinant DNA, and bioinformatics for sequencing, assembling, and analysing
genome structure and function. The growing use of NGS (Next-Generation
Sequencing) in cancer research, combined with the influx of new players and
start-ups, will fuel the industry's revenue growth.
Consumables are expected to proliferate through 2026 due to
their growing utility in genomic systems due to their disposable nature and
ultimate safety for health workers. They are a highly sought-after solution
because they provide protection against airborne particles as well as harsh
liquids that can cause severe skin damage. The growing number of genomic tests
performed globally, as well as the increasing availability of nucleic acid
extraction kits and reagents, will also favour segment progression.\
The development of novel genome technologies by key players
in the genomics
market, as well as a diverse range of genomic products used in COVID-19
research, aided researchers in their understanding of the coronavirus. As a
result, COVID-19 had a positive impact on the genomics market. Using existing
genetic databases, researchers attempted to address genetic severity and
susceptibility to SARS-CoV-2 infection. To uncover the common variants
underlying host-pathogen interactions and biological networks, genome-wide
association studies (GWAS) and multiomic-based approaches have been used.
Furthermore, data from genomes, such as ABO blood groups and polygenic risk
scores (PRS), could be used to decode COVID-19 susceptibility, complications,
and resistance. Furthermore, biobanks that link genomic data to electronic
health records can be used to study the impact of genomic factors on the
clinical course of COVID-19 patients.
Comments
Post a Comment